| Financial Year |
March 31 2023 |
| Monetary Funds |
48,038,369.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
702,000.00 |
| Accounts Receivable |
138,170,643.10 |
| Advances to Suppliers |
10,813,758.12 |
| Other Receivables |
2,364,035.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
158,022,696.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,924,612.56 |
| Total Current Assets |
393,036,115.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,259,329.90 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
118,969.33 |
| Other Non-Current Assets |
400,000.00 |
| Sub-Total of Non-Current Assets |
2,821,783.41 |
| Total Assets |
395,857,898.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
13,211,053.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
879,077.91 |
| Taxes Payable |
23,360,784.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
48,277,642.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,439.85 |
| Other Current Liabilities |
6,944.28 |
| Sub-Total of Current Liabilities |
86,561,907.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
887,342.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
887,342.00 |
| Total Liabilities |
87,449,249.19 |
| Paid-In Capital(Or Share Stock) |
689,184,933.00 |
| Capital Surplus |
778,824,470.95 |
| Surplus Reserve |
32,673,227.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,207,704,654.73 |
| Minority Stockholder's Interest |
15,430,673.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
292,977,976.23 |
| Owner's Equity（Stockholder's Equity） |
308,408,649.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
395,857,898.71 |
